‘Revolutionary’: Albo Inks Massive AI Deal
news.com.au
SKIPPED
Details
- Date Published
- 1 Apr 2026
- Priority Score
- 5
- Australian
- Yes
- Created
- 1 Apr 2026, 12:00 am
Description
US-based artificial intelligence company Anthropic has signed a massive deal with the Albanese government, and will offer its services to several Australian research institutes that are aiming to advance disease diagnosis and treatment.
Summary
The Australian Government has established a formal partnership with Anthropic to collaborate on AI safety research and sector-wide AI adoption across natural resources, healthcare, and finance. The agreement includes data sharing with Australia’s AI Safety Institute to evaluate emerging model capabilities and catastrophic risks, mirroring safe-guarding frameworks in the US and UK. While focused heavily on medical research applications, the deal signifies a major step in the Australian government’s effort to institutionalize governance around frontier AI models and their potential societal implications.
Body
Federal government strikes major deal with US-based AI giant Anthropic for research, investmentsA US-based artificial intelligence company is bringing its technology to Australian researchers after the federal government signed a huge deal.Angie Raphael2 min readApril 1, 2026 - 9:30AMNewsWireUS-based artificial intelligence company Anthropic has signed a massive deal with the Albanese government, and will offer its services to several Australian research institutes that are aiming to advance disease diagnosis and treatment.Under the Memorandum of Understanding, the AI safety company will share Anthropic Economic Index data with the Australian government to examine how AI is being adopted across the economy and the implications for workers.Natural resources, agriculture, healthcare and financial services will be the first sectors involved — with a plan to advance AI training in the workforce.Working with Australia’s AI Safety Institute, the company will share findings on emerging model capabilities and risks, participate in joint safety and security evaluations, and collaborate on research with Australian academic institutions. The company has similar arrangements in the US, UK and Japan.“Australia’s investment in AI safety makes it a natural partner for responsible AI development,” Anthropic chief executive Dario Amodei said.“This MOU gives our collaboration a formal foundation.”Prime Minister Anthony Albanese signed the deal with the company. Picture: NewsWire / Martin OllmanMr Amodei, who met with the Prime Minister in Canberra to seal the deal, also announced $3m in partnerships with research institutions to use the technology Claude.Partnerships will be with the Australian National University, Murdoch Children’s Research Institute, the Garvan Institute of Medical Research and Curtin University.One project involves a team from ANU’s John Curtin School of Medical Research using Claude to analyse genetic sequencing data to combat rare diseases. “Turning genomic data into real diagnoses has always depended on highly specialised knowledge — expertise built over decades of clinical experience and deep familiarity with the scientific literature,” Associate Professor Dan Andrews said.“Until now, that knowledge couldn’t be automated. The clinical pay-off will be transformative: more patients diagnosed, with direct implications for precision medicine.“With Claude Code, we’re creating bespoke AI tools so quickly that it’s forced us to think much bigger than we ever imagined. “The size and importance of the problems we can now practically contemplate solving is revolutionary, and we’re only just at the very beginning of what is possible.”The ANU School of Computing is also embedding Claude into new courses to train future developers and scientists.The Curtin Institute for Data Science will use Claude to research projects across health sciences, the humanities, business, law, science and engineering.The Garvan Institute of Medical Research will use Claude to accelerate genomic discovery in two major research projects. The first, with UNSW, will build systems that translate human genetic variation into insights about how disease operates in specific cell types, with the goal of identifying new treatments. The second, with the Centre for Population Genomics, will automate the complex genetic analysis that is currently slowing the diagnosis of children with rare genetic disorders.Separately, Murdoch Children’s Research Institute will use Claude for its stem cell medicine program to improve identification of therapeutic targets for childhood heart disease. UNSW Professor Joseph Powell said the project tackled “one of the biggest challenges in modern biology”. “We’ve become very good at finding the genetic signals linked to disease, but much less effective at understanding how they lead to disease in specific cells,” he said. “By combining large-scale human genetics at single-cell resolution with Anthropic’s Claude, we can convert those signals into actionable biological insight and identify where they can be targeted for treatment.”The Curtin Institute for Data Science will use Claude to research projects across health sciences, the humanities, business, law, science and engineering.More related storiesMilitaryDevastating new Iran threat emergesExperts have sounded the alarm over Iran’s truly terrifying secret weapons - and apparently, “the risk has escalated significantly”.Read moreMilitaryTrump stuns the world with Iran twistFor weeks, Donald Trump has held firm in his stance that Iran must be stopped. Now, he’s changing his tune on one huge thing.Read moreMilitary‘Nowhere is safe’: Iran’s new ‘global’ threatA chilling new threat has triggered concerns on a global scale, with claims Iran’s capabilities far exceed what was previously known to us.Read more